Shared decision-making improves adherence to mesalamine in ulcerative colitis: A prospective, multicenter, non-interventional cohort study in Germany

Figure 2 Patient preference for mesalamine. A: Relationship between accommodation of patient preference for mesalamine formulation and adherence to treatment over 12 months. Horizontal lines within the boxes indicate median values, and the caps at the ends of the whiskers indicate minimum and maximum values; B: Mean partial Mayo (pMayo) scores for ulcerative colitis patients with good adherence or suboptimal adherence to oral mesalamine at Visit 1 (month 0), Visit 2 (months 4-8), and Visit 3 (month 12). A higher score on the pMayo indicates greater disease activity. Good adherence is defined as a score ≤ 2 and suboptimal adherence as a score > 2 on the employed visual analogue scale (VAS). Crosses indicate mean values, and the caps at the end of the whiskers indicate minimum and maximum values; C: Relationship between accommodation of patient preference for mesalamine formulation and disease activity (pMayo) over 12 months. Crosses indicate mean values, and the caps at the end of the whiskers indicate minimum and maximum values.